More articles from Commentary

  • Our evolving understanding of primary aldosteronism
    Ali Mehdi, MD, MEd, FACP, Pratibha Rao, MD, MPH and George Thomas, MD
    Cleveland Clinic Journal of Medicine April 2021, 88 (4) 221-227; DOI: https://doi.org/10.3949/ccjm.88a.20166

    Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.

  • Cleveland Clinic Journal of Medicine: Evolution and a look ahead
    James S. Taylor, MD, FAAD
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 11-13; DOI: https://doi.org/10.3949/ccjm.88a.20187

    Cleveland Clinic is 100 years old and has had a medical journal for 90 of those years.

  • COVID-19 diagnostic testing and the psychology of precautions fatigue
    Gregory W. Ruhnke, MD, MS, MPH
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 19-21; DOI: https://doi.org/10.3949/ccjm.88a.20086

    Overuse of special precautions can lead to diminished vigilance.

  • Prostate cancer screening and the role of PSA: A UK perspective
    Prasanna Sooriakumaran, MD, PhD, FRCSUrol, FEBU
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 14-16; DOI: https://doi.org/10.3949/ccjm.88a.20164

    We advocate PSA screening for all middle-aged men, especially if they have risk factors.

  • Cleveland Clinic—A century of progress
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.88a.20185

    No one in their right mind would want to return to the “good old days.”

  • Is regular oxygen supplementation safe for obese postoperative patients?
    Roop Kaw, MD and Anthony G. Doufas, MD, PhD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 723-727; DOI: https://doi.org/10.3949/ccjm.87a.19051

    Caution for some, but no evidence to support withholding it altogether.

  • COVID-19 and flu: Dual threat, dual opportunity
    Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
    Cleveland Clinic Journal of Medicine November 2020, 87 (11) 651-655; DOI: https://doi.org/10.3949/ccjm.87a.20161

    Measures to combat COVID-19 can minimize the impact of flu, and vice versa.

  • Overcoming obesity: Weight-loss drugs are underused
    Amjad Kanj, MD, MPH and Diane Levine, MD, FACP
    Cleveland Clinic Journal of Medicine October 2020, 87 (10) 602-604; DOI: https://doi.org/10.3949/ccjm.87a.19102

    Successful management of obesity requires a multifaceted approach.

  • Emerging blood-based biomarkers for Alzheimer disease
    Lynn M. Bekris, PhD and James B. Leverenz, MD
    Cleveland Clinic Journal of Medicine September 2020, 87 (9) 537-539; DOI: https://doi.org/10.3949/ccjm.87a.20133

    A blood test for Alzheimer disease could help in drug development and patient care.

  • Stable coronary artery disease: Intervene or not?
    Vinayak Nagaraja, MBBS, MS, MMed (Clin Epi), FRACP and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 410-415; DOI: https://doi.org/10.3949/ccjm.87a.20048

    Stable coronary artery disease needs a patient-centered approach, and one size does not fit all.

Pages